SCHEMBL23079025

SCHEMBL23079025

BC(=O)c1cccc(Br)c1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 1/20 0.69
ALDH1A1 P00352 5/20 0.55
TP53 P04637 1/20 0.55
C1S P09871 1/20 0.52
HPGD P15428 2/20 0.52
L3MBTL1 Q9Y468 1/20 0.50
SMN1; SMN2 Q16637 4/20 0.49
NPC1 O15118 2/20 0.46
TSHR P16473 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
GAA P10253 1/20 0.46
NFKB1 P19838 1/20 0.46
NFKB2 Q00653 1/20 0.46
RELA Q04206 1/20 0.46
MAPT P10636 2/20 0.45
BCHE P06276 1/20 0.45
SLC6A3 Q01959 1/20 0.45
CYP1A2 P05177 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL163949 0.82 PARP1 (1.00) PARP1ALDH1A1TP53C1SHPGD
SCHEMBL16803128 0.82 PARP1 (1.00) PARP1ALDH1A1TP53C1SHPGD
SCHEMBL241785 0.81 PARP1 (0.68) PARP1ALDH1A1TP53C1SHPGD
SCHEMBL6670439 0.81 PARP1 (0.68) PARP1ALDH1A1TP53C1SHPGD
SCHEMBL30153175 0.81 PARP1 (0.68) PARP1ALDH1A1TP53C1SHPGD
Hydrochloric Acid SCHEMBL4376137 0.80 PARP1 (0.96) PARP1ALDH1A1TP53C1SHPGD
Hydrochloric Acid SCHEMBL5319538 0.80 PARP1 (0.96) PARP1ALDH1A1TP53C1SHPGD
SCHEMBL5023 0.79 PARP1 (0.65) PARP1ALDH1A1TP53C1SHPGD
SCHEMBL8681033 0.79 PARP1 (0.65) PARP1ALDH1A1TP53C1SHPGD
SCHEMBL180430 0.79 PARP1 (0.65) PARP1ALDH1A1TP53C1SHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021045879-A1 SYNTHESIS OF DEUTERATED ALDEHYDES ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) 2021-03-11 WO disclosed
US-20160346270-A1 BENZOQUINOLINE INHIBITORS OF VESICULAR MONOAMINE TRANSPORTER 2 AUSPEX PHARMACEUTICALS, INC. 2016-12-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160346270-A1 BENZOQUINOLINE INHIBITORS OF VESICULAR MONOAMINE TRANSPORTER 2 SLC18A2, SLC6A2, SLC18A1 PARP1 3647/4885ALDH1A1 538/4885TP53 4856/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.